XG Sciences is a private company based in Michigan, US, that develops and producer graphene flakes using technology developed at Michigan State University.
XG Sciences uses its xGnP (graphene flakes) materials to also develop graphene applications. In August 2013, XGS launched a new graphene-based anode material for Li-Ion batteries. In August 2012 the company started production in their new 80 ton facility in Lansing, MI.
In 2014 Samsung Ventures placed a strategic investment in XGS as the two companies aim to co-develop graphene-enhanced batteries. In July 2013 we posted an interview with the company's co-founder and CEO.
Towards the end of 2018 XGS announced its production capacity has been expanded to 180 tons per year, with plans for further expansion to 400 tons/year.
The latest XG Sciences graphene news:
US-based graphene developer XG Sciences recently made headlines with a production expansion announcement - and an exciting deal with Ford to supply it with graphene-enhanced parts for the latest the Mustang and F-150 automobiles.
We have reached out to XGS' CEO, Philip Rose, who was kind enough to answer a few questions we had regarding the company's latest materials, plans and business.
Automotive giant Ford has announced that it will become the first automaker to use graphene parts in its vehicles, starting with the Mustang and F-150 by the end of 2018.
Ford acknowledges the difficulties of graphene manufacturing and use, but in partnership with Eagle Industries and XG Sciences, it has determined a way to make use of graphene reinforcement in certain components to strengthen and lighten them, as well as reduce noise. Since 2014, Ford and its partners have tested graphene-reinforced foam covers for noisy components such as the fuel rail, pumps, and belt-driven pulleys or chain-driven gears on the front of engines. The graphene is mixed with foam constituents, and the resulting parts are said to be 17% quieter, 20% stronger, and 30% more heat-resistant.
XG Sciences has announced the completion of the first phase of expansion in its newest 64,000 square-foot facility. The expansion has added 90 metric tons of graphene nanoplatelet production capacity, bringing the total capacity of the facility up to approximately 180 metric tons and enabling the formulation of up to 18 million kilograms of advanced materials per year. Phase two of the expansion is expected to be complete by year-end and will result in up to 400 metric tons of total graphene nanoplatelet output capacity at the facility.
XG's total graphene nanoplatelet output capacity across both of its manufacturing facilities currently exceeds 200 metric tons per year and will more than double over the next three months, reaching up to an approximate 450 metric tons by year-end. The expansions support XG’s mission to continue commercializing the use of graphene in customer products across diverse industries.
XG Sciences, a US-based developer and producer of graphene flakes, has announced its plan to invest millions in expanding its Lansing-area facilities. The company will start operating out of new 64,000 square-foot facility in Vevay Township in March.
The company was formed in 2006 based on work out of Michigan State University. The company's technology can be used in automotive batteries and as wire coatings in electronics to prevent microchips from overheating. Some of the material has been used in Samsung phones as a thermally conductive adhesive, said current CEO Philip Rose. Rose also said the expansion marks the first phase in a move toward larger scale commercialization for the company.
XG Sciences, a supplier of graphene nanoplatelets and value-added products containing graphene nanoplatelets, recently announced that it has closed an agreement with The Dow Chemical Company for up to a $10 million senior credit facility, which may be drawn down in tranches by XGS at its discretion through December 2019.
The company received $2 million under this facility at close and may draw another $3 million at its discretion at any time prior to the first anniversary of the agreement. After the first anniversary of the closing, the company may access the remaining $5 million, provided it has raised at least $10 million of additional equity capital. XG Sciences and Dow agreed to hold commercial discussions including the potential out-license of certain of Dow’s manufacturing IP related to graphene nanoplatelets to XGS.